Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_assertion wasGeneratedBy ECO_0000203 NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_assertion wasDerivedFrom befree-20150227 NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_assertion SIO_000772 21805029 NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_assertion evidence source_evidence_literature NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.
- NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_assertion description "[In conclusion, our results demonstrate the ability of hydralazine and valproate to increase the NK activity against epithelial cancer cell lines and suggest that these drugs could reduce the levels of soluble MICA and MICB helping in avoiding tumor-induced suppression of NK cytotoxicity against the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014734.RAAyp5dESBZ4UhOT6PjbzfnfHzXlK5Km4z6VZft_64IY0130_provenance.